Angioedema: Differential diagnosis and treatment

Allergy and Asthma Proceedings

Volumn 32, Issue SUPPL. 1, 2011, Pages

  Busse, Paula J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; ANALGESIC AGENT; ANDROGEN; ANTIHISTAMINIC AGENT; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DANAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; ECALLANTIDE; FRESH FROZEN PLASMA; HYDROCORTISONE; ICATIBANT; IMMUNOGLOBULIN E ANTIBODY; INFUSION FLUID; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PROGESTERONE; TRANEXAMIC ACID;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABSENCE OF SIDE EFFECTS; ACQUIRED ANGIOEDEMA; ALLERGIC ANGIOEDEMA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANUS PRURITUS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; FATIGUE; GENE MUTATION; HEADACHE; HEAT; HUMAN; HUNGER; IDIOPATHIC ANGIOEDEMA; INTUBATION; MALAISE; MEDICATION INDUCED ANGIOEDEMA; MUSCLE WEAKNESS; MYALGIA; NAUSEA; ORTHOSTATIC HYPOTENSION; PRURITUS; REVIEW; SKIN BURNING SENSATION; SKIN SWELLING; SKIN TINGLING; THROMBOSIS; TRACHEOTOMY; UNITED STATES; URTICARIA;

ANGIOEDEMA; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 80054024330     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3464     Document Type: Review

References (43)

1. Weldon D. Differential diagnosis of angioedema. Immunol Allergy Clin North Am 26:603-613, 2006. (Pubitemid 44666310)
2. Kaplan AP, and Greaves MW. Angioedema. J Am Acad Dermatol 53:373-388, 2005. (Pubitemid 41195957)
3. Frigas E, and Nzeako UC. Angioedema. Pathogenesis, differential diagnosis, and treatment. Clin Rev Allergy Immunol 23:217-231, 2002. (Pubitemid 34971905)
4. Bork K. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor. Allergy Asthma Clin Immunol 6:15, 2010.
5. Nzeako UC, Frigas E, and Tremaine WJ. Hereditary angioedema as a cause of transient abdominal pain. J Clin Gastroenterol 34:57-61, 2002. (Pubitemid 34038481)
6. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 359:1027-1036, 2008.
7. Bowen T, Cicardi M, Farkas H, et al. International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6:24, 2010.
8. Prematta MJ, Kemp JG, Gibbs JG, et al. Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. Allergy Asthma Proc 30:506-511, 2009.
9. Kemp JG, and Craig TJ. Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: A literature review. Allergy Asthma Proc 30:493-499, 2009.
10. Agostoni A, Aygoren-Pursun E, Binkley KE, et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51-S131, 2004. (Pubitemid 39200689)
11. Bork K, Meng G, Staubach P, and Hardt J. Hereditary angioedema: New findings concerning symptoms, affected organs, and course. Am J Med 119:267-274, 2006. (Pubitemid 43255068)
12. Frank MM. Hereditary angioedema: The clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 26:653-668, 2006. (Pubitemid 44666309)
13. Frank MM, Gelfand JA, and Atkinson JP. Hereditary angioedema: The clinical syndrome and its management. Ann Intern Med 84:580-593, 1976.
14. Frank H, Hardeland R, and Frank A. On the induction of the hepatic tyrosine aminotransferase by quinolinic acid. Arch Int Physiol Biochim 84:471-477, 1976.
15. Agostoni A, and Cicardi M. Hereditary and acquired C1-inhibitor deficiency: Biological and clinical characteristics in 235 patients. Medicine (Baltimore) 71:206-215, 1992.
16. Bork K, Gul D, Hardt J, and Dewald G. Hereditary angioedema with normal C1 inhibitor: Clinical symptoms and course. Am J Med 120:987-992, 2007. (Pubitemid 47633496)
17. Cicardi M, Zingale LC, Pappalardo E, et al. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 82:274-281, 2003. (Pubitemid 36859223)
18. Zingale LC, Castelli R, Zanichelli A, and Cicardi M. Acquired deficiency of the inhibitor of the first complement component: Presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 26:669-690, 2006. (Pubitemid 44666305)
19. Byrd JB, Adam A, and Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 26:725-737, 2006. (Pubitemid 44679724)
20. Malde B, Regalado J, and Greenberger PA. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 98:57-63, 2007. (Pubitemid 46106159)
21. Sanchez-Borges M, Capriles-Hulett A, and Caballero-Fonseca F. NSAID-induced urticaria and angioedema: A reappraisal of its clinical management. Am J Clin Dermatol 3:599-607, 2002. (Pubitemid 36009055)
22. Kelkar PS, Butterfield JH, and Teaford HG. Urticaria and angioedema from cyclooxygenase-2 inhibitors. J Rheumatol 28:2553-2554, 2001. (Pubitemid 33031992)
23. Kumar NP, Wild G, Ramasamy KA, and Snape J. Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib. Postgrad Med J 78:439-440, 2002. (Pubitemid 34824251)
24. Frigas E, and Park M. Idiopathic recurrent angioedema. Immunol Allergy Clin North Am 26:739-751, 2006. (Pubitemid 44666308)
25. Bork K, Barnstedt SE, Koch P, and Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356:213-217, 2000. (Pubitemid 30446977)
26. Schwartz LB, Yunginger JW, Miller J, et al. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 83:1551-1555, 1989. (Pubitemid 19124110)
27. Sabroe RA, Grattan CE, Francis DM, et al. The autologous serum skin test: A screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140:446-452, 1999. (Pubitemid 29182875)
28. Niimi N, Francis DM, Kermani F, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 106:1001-1006, 1996. (Pubitemid 26153503)
29. Ferrer M, Kinet JP, and Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 101:672- 676, 1998.
30. Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 124:801-808, 2009.
31. Cicardi M, Levy RJ, McNeil DL, et al. Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med 363:523-531, 2010.
32. Cicardi M, Banerji A, Bracho F, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 363:532-541, 2010.
33. Lumry WR, Li HH, Levy RJ, et al. Results from FAST-3: A phase iii randomized, double-blind, placebo-controlled, multicenter study of subcutaneous icatibant in patients with acute hereditary angioedema (HAE) attacks. J Allergy Clin Immunol 127:AB1, 2011.
34. Craig T, Riedl M, Dykewicz MS, et al. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol 102:366-372, 2009.
35. Bork K, Bygum A, and Hardt J. Benefits and risks of danazol in hereditary angioedema: A long-term survey of 118 patients. Ann Allergy Asthma Immunol 100:153-161, 2008. (Pubitemid 351238551)
36. Longhurst HJ, Farkas H, Craig T, et al. HAE international home therapy consensus document. Allergy Asthma Clin Immunol 6:22, 2010.
37. Bygum A, Andersen KE, and Mikkelsen CS. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur J Dermatol 19:147-151, 2009.
38. Zuraw BL, Busse PJ, White M, et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 363:513-522, 2010.
39. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am 26:709-724, 2006. (Pubitemid 44666307)
40. Bork K, Wulff K, Hardt J, et al. Hereditary angioedema caused by missense mutations in the factor XII gene: Clinical features, trigger factors, and therapy. J Allergy Clin Immunol 124:129-134, 2009.
41. Nielsen EW, and Gramstad S. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand 50:120-122, 2006. (Pubitemid 43339042)
42. Warrier MR, Copilevitz CA, Dykewicz MS, and Slavin RG. Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema. Ann Allergy Asthma Immunol 92:573-575, 2004. (Pubitemid 39236822)
43. Temino VM, and Peebles RS Jr. The spectrum and treatment of angioedema. Am J Med 121:282-286, 2008. (Pubitemid 351417834)